XML 45 R33.htm IDEA: XBRL DOCUMENT v3.20.2
Merger (Tables)
6 Months Ended
Jun. 30, 2020
Business Combinations [Abstract]  
Schedule of Business Acquisitions, by Acquisition The table below summarizes the ownership of the combined company ("TCF Financial") following the Merger, as well as the market capitalization of the combined company using shares of Chemical and Legacy TCF common stock outstanding at July 31, 2019 and Chemical’s closing price on July 31, 2019.
(Dollars in thousands)
 TCF Financial Ownership and Market Value Table
 
 Number of Chemical Outstanding Shares
 
 Percentage Ownership
 
 Market Value at $42.04 Chemical Share Price
Legacy TCF shareholders
81,920,494

 
53.38
%
 
$
3,443,938

Chemical shareholders
71,558,755

 
46.62

 
3,008,330

 Total
153,479,249

 
100.00
%
 
$
6,452,268



Next, the hypothetical number of shares Legacy TCF would have to issue to give Chemical owners the same percentage ownership in the combined company is calculated in the table below (based on shares of Legacy TCF common stock outstanding at July 31, 2019):
 
 
 Hypothetical Legacy TCF Ownership
 
 
 Number of Legacy TCF Outstanding Shares
 
 Percentage Ownership
Legacy TCF shareholders
 
161,229,078

 
53.38
%
Chemical shareholders
 
140,835,967

 
46.62

 Total
 
302,065,045

 
100.00
%


Finally, the purchase price is calculated based on the number of hypothetical shares of Legacy TCF common stock issued to Chemical shareholders multiplied by the share price as demonstrated in the table below.
(Dollars in thousands, except per share data)
 
 
Number of hypothetical Legacy TCF shares issued to Chemical shareholders
140,835,967

Legacy TCF market price per share as of July 31, 2019
$
21.38

Purchase price determination of hypothetical Legacy TCF shares issued to Chemical shareholders
3,011,073

Value of Chemical stock options hypothetically converted to options to acquire shares of Legacy TCF common stock
7,335

Cash in lieu of fractional shares
148

Purchase price consideration
$
3,018,556



Schedule of Recognized Identified Assets Acquired and Liabilities Assumed
The following table provides the purchase price allocation as of the Merger Date and the assets acquired and liabilities assumed at their estimated fair value as of the Merger Date as recorded by the Corporation. The Corporation recorded the estimate of fair value based on initial valuations available at the Merger Date and these estimates are considered preliminary and subject to adjustment for up to one year after the Merger Date. While the Corporation believes that the information available at the Merger Date provided a reasonable basis for estimating fair value, following the Merger, the Corporation obtained additional information and evidence and then finalized all valuations and recorded final adjustments during the first quarter of 2020. These adjustments included: (i) changes in the estimated fair value of loans and leases acquired, (ii) changes in deferred tax assets related to fair value estimates and changes in the expected realization of items considered to be net operating loss carryforwards, and (iii) changes in goodwill as a result of the net effect of any adjustments.
(In thousands)
 
Purchase price consideration:
 
Stock
$
3,018,556

Fair value of assets acquired(1)
 
Cash and cash equivalents
975,014

Federal Home Loan Bank and Federal Reserve Bank stocks
218,582

Investment securities
3,774,738

Loans held-for-sale
44,532

Loans and leases
15,713,399

Premises and equipment
140,219

Loan servicing rights
59,567

Other intangible assets
159,532

Net deferred tax asset(2)
65,685

Other assets
552,432

Total assets acquired
21,703,700

Fair value of liabilities assumed(1)
 
Deposits
16,418,215

Short-term borrowings
2,629,426

Long-term borrowings
442,323

Other liabilities
353,469

Total liabilities assumed
19,843,433

Fair value of net identifiable assets
1,860,267

Goodwill resulting from Merger(1)
$
1,158,289

(1)
All amounts were previously reported in the Corporation's Annual Report on Form 10-K for the year ended December 31, 2019, with the exception of the following adjustments to fair value based on additional information obtained in the first quarter of 2020: (i) loans and leases ($17.2 million decrease), (ii) net deferred tax asset ($4.0 million increase), and (iii) goodwill resulting from Merger ($13.2 million increase).
(2)
Net deferred tax asset includes acquisition-related fair value adjustments, loss and tax credit carry forwards, mortgage servicing rights and core deposit and customer intangibles.

Summary of PCI Loans
Information regarding acquired loans and leases included in net loans and leases acquired at the Merger Date was as follows:
(In thousands)
 
PCI loans:
 
Contractually required payments receivable
$
413,176

Nonaccretable difference
(63,014
)
Expected cash flows
350,162

Accretable yield
38,479

Fair value of PCI loans
$
311,683

 
 
Purchased nonimpaired loans and leases:
 
Unpaid principal balance
$
15,636,020

Fair value discount
(234,304
)
Fair value at acquisition
15,401,716

    Total fair value at acquisition
$
15,713,399


Business Acquisition, Pro Forma Information The following pro forma financial information presents the consolidated results of operations of Legacy TCF and Chemical as if the Merger had occurred as of January 1, 2019 with pro forma adjustments. The pro forma adjustments give effect to any change in interest income due to the accretion of the discount (amortization of premium) associated with the fair value adjustments to acquired loans and leases, any change in interest expense due to estimated premium amortization/discount accretion associated with the fair value adjustments to acquired time deposits and borrowings and other debt, amortization of the customer relationship intangibles, and amortization of the core deposit intangibles that would have resulted had the deposits been acquired as of January 1, 2019. Merger-related expenses incurred by TCF during the three and six months ended June 30, 2020 are not reflected in the pro forma amounts. The pro forma information does not necessarily reflect the results of operations that would have occurred had Legacy TCF merged with Chemical at the beginning of 2019. Anticipated cost savings that have not yet been realized are also not reflected in the pro forma amounts for the three and six months ended June 30, 2020 and 2019.
 
Three Months Ended June 30,
 
Six Months Ended June 30,
(In thousands, except per share data)
2020
 
2019
 
2020
 
2019
Net interest income and other noninterest income
$
511,413

 
$
576,210

 
$
1,049,857

 
$
1,130,934

Net income
23,764

 
169,814

 
75,663

 
318,881

Net income available to common shareholders
21,270

 
167,320

 
70,676

 
313,894

Earnings per share:
 
 
 
 
 
 
 
Basic
$
0.14

 
$
1.09

 
$
0.47

 
$
2.04

Diluted
0.14

 
1.08

 
0.47

 
2.03